Comparison of test performance of commercial anti-SARS-CoV-2 immunoassays in serum and plasma samples

BACKGROUND: For epidemiologic, social and economic reasons, assessment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection prevalence and immunity are important to adapt decisions to current demands. Hence, immunoassays for detection of anti-SARS-CoV-2 antibodies are introduced...

Descripción completa

Detalles Bibliográficos
Autores principales: Haselmann, Verena, Kittel, Maximilian, Gerhards, Catharina, Thiaucourt, Margot, Eichner, Romy, Costina, Victor, Neumaier, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343640/
https://www.ncbi.nlm.nih.gov/pubmed/32652161
http://dx.doi.org/10.1016/j.cca.2020.07.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343640/
https://www.ncbi.nlm.nih.gov/pubmed/32652161
http://dx.doi.org/10.1016/j.cca.2020.07.007

Ejemplares similares